Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,385 public trials 2,846 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

NCT00006246

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +57 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

NCT00143312

Conditions
Bacterial Infections and Mycoses, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Marseille, Cedex 09, France
  • Pfizer Investigational Site Créteil, France
  • Pfizer Investigational Site Nantes, France
View all 17 locations
View Trial Details
Completed

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

NCT00512083

Conditions
Acute Disease, Disease Attributes, Hematologic Diseases, +7 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Univeristy of Colorado Health Cancer Center Aurora, Colorado, United States
  • St. Francis Hospital and Health Center Beech Grove, Indiana, United States
  • University of Louisville, James Graham Brown Cancer Center Louisville, Kentucky, United States
View Trial Details
Completed

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

NCT00220766

Conditions
Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +24 more
Locations
  • Departments of Medicine and Microbiology Birmingham, Alabama, United States
  • National Jewish Medical and Researach Center Denver, Colorado, United States
  • International Center for Interdisciplinary Studies of Immunology Washington D.C., District of Columbia, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Completed

Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

NCT00425347

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • USC/Norris Cancer Hospital Los Angeles, California, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions